Growth hormone and Prader-Willi syndrome

Aaron L. Carrel, Phillip Lee, Harriette R. Mogul

Research output: Chapter in Book/Report/Conference proceedingChapter

19 Citations (Scopus)

Abstract

In the previous edition of this textbook, various lines of evidence for the occurrence of a defi ciency in the growth hormone (GH) axis were reviewed as one of several sections in a chapter entitled "Endocrine and Metabolic Aspects of Prader-Willi Syndrome."76 At that time, it was suggested that GH therapy may have benefi cial effects on growth and body composition in individuals with PWS. Over the succeeding decade, a number of scientifi c investigations have provided defi nitive evidence in support of these suggestions.16,37,72,73 In 2000, biosynthetic GH became the fi rst and, to date, only medication to receive regulatory approval for treatment of children with PWS. In addition, it appears that GH may also have potential utility in adults with PWS.61,86 This chapter presents a comprehensive review of relevant physiology and pathophysiology of the GH system and GH treatment effi cacy and safety in PWS.

Original languageEnglish (US)
Title of host publicationManagement of Prader-Willi Syndrome: Third Edition
PublisherSpringer New York
Pages201-241
Number of pages41
ISBN (Print)0387253971, 9780387253978
DOIs
StatePublished - 2006
Externally publishedYes

Fingerprint

Prader-Willi Syndrome
Growth Hormone
Textbooks
Body Composition
Therapeutics
Safety
Growth

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Carrel, A. L., Lee, P., & Mogul, H. R. (2006). Growth hormone and Prader-Willi syndrome. In Management of Prader-Willi Syndrome: Third Edition (pp. 201-241). Springer New York. https://doi.org/10.1007/978-0-387-33536-0_7

Growth hormone and Prader-Willi syndrome. / Carrel, Aaron L.; Lee, Phillip; Mogul, Harriette R.

Management of Prader-Willi Syndrome: Third Edition. Springer New York, 2006. p. 201-241.

Research output: Chapter in Book/Report/Conference proceedingChapter

Carrel, AL, Lee, P & Mogul, HR 2006, Growth hormone and Prader-Willi syndrome. in Management of Prader-Willi Syndrome: Third Edition. Springer New York, pp. 201-241. https://doi.org/10.1007/978-0-387-33536-0_7
Carrel AL, Lee P, Mogul HR. Growth hormone and Prader-Willi syndrome. In Management of Prader-Willi Syndrome: Third Edition. Springer New York. 2006. p. 201-241 https://doi.org/10.1007/978-0-387-33536-0_7
Carrel, Aaron L. ; Lee, Phillip ; Mogul, Harriette R. / Growth hormone and Prader-Willi syndrome. Management of Prader-Willi Syndrome: Third Edition. Springer New York, 2006. pp. 201-241
@inbook{a1fd0479418947e5b0704d97223cf8f7,
title = "Growth hormone and Prader-Willi syndrome",
abstract = "In the previous edition of this textbook, various lines of evidence for the occurrence of a defi ciency in the growth hormone (GH) axis were reviewed as one of several sections in a chapter entitled {"}Endocrine and Metabolic Aspects of Prader-Willi Syndrome.{"}76 At that time, it was suggested that GH therapy may have benefi cial effects on growth and body composition in individuals with PWS. Over the succeeding decade, a number of scientifi c investigations have provided defi nitive evidence in support of these suggestions.16,37,72,73 In 2000, biosynthetic GH became the fi rst and, to date, only medication to receive regulatory approval for treatment of children with PWS. In addition, it appears that GH may also have potential utility in adults with PWS.61,86 This chapter presents a comprehensive review of relevant physiology and pathophysiology of the GH system and GH treatment effi cacy and safety in PWS.",
author = "Carrel, {Aaron L.} and Phillip Lee and Mogul, {Harriette R.}",
year = "2006",
doi = "10.1007/978-0-387-33536-0_7",
language = "English (US)",
isbn = "0387253971",
pages = "201--241",
booktitle = "Management of Prader-Willi Syndrome: Third Edition",
publisher = "Springer New York",

}

TY - CHAP

T1 - Growth hormone and Prader-Willi syndrome

AU - Carrel, Aaron L.

AU - Lee, Phillip

AU - Mogul, Harriette R.

PY - 2006

Y1 - 2006

N2 - In the previous edition of this textbook, various lines of evidence for the occurrence of a defi ciency in the growth hormone (GH) axis were reviewed as one of several sections in a chapter entitled "Endocrine and Metabolic Aspects of Prader-Willi Syndrome."76 At that time, it was suggested that GH therapy may have benefi cial effects on growth and body composition in individuals with PWS. Over the succeeding decade, a number of scientifi c investigations have provided defi nitive evidence in support of these suggestions.16,37,72,73 In 2000, biosynthetic GH became the fi rst and, to date, only medication to receive regulatory approval for treatment of children with PWS. In addition, it appears that GH may also have potential utility in adults with PWS.61,86 This chapter presents a comprehensive review of relevant physiology and pathophysiology of the GH system and GH treatment effi cacy and safety in PWS.

AB - In the previous edition of this textbook, various lines of evidence for the occurrence of a defi ciency in the growth hormone (GH) axis were reviewed as one of several sections in a chapter entitled "Endocrine and Metabolic Aspects of Prader-Willi Syndrome."76 At that time, it was suggested that GH therapy may have benefi cial effects on growth and body composition in individuals with PWS. Over the succeeding decade, a number of scientifi c investigations have provided defi nitive evidence in support of these suggestions.16,37,72,73 In 2000, biosynthetic GH became the fi rst and, to date, only medication to receive regulatory approval for treatment of children with PWS. In addition, it appears that GH may also have potential utility in adults with PWS.61,86 This chapter presents a comprehensive review of relevant physiology and pathophysiology of the GH system and GH treatment effi cacy and safety in PWS.

UR - http://www.scopus.com/inward/record.url?scp=33750619758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750619758&partnerID=8YFLogxK

U2 - 10.1007/978-0-387-33536-0_7

DO - 10.1007/978-0-387-33536-0_7

M3 - Chapter

SN - 0387253971

SN - 9780387253978

SP - 201

EP - 241

BT - Management of Prader-Willi Syndrome: Third Edition

PB - Springer New York

ER -